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Abstract 
 
Metabolic reprogramming from mitochondrial aerobic respiration to 
aerobic glycolysis is a hallmark of cancer. However, whether it is caused by a 
dysfunction in the oxidative phosphorylation pathway is still under debate. In this 
work, we have analyzed the bioenergetic cellular (BEC) index and the relative cell 
ability to grow in the presence of either galactose or glucose as sources of sugar 
(Gal/Glu index) of a system formed by four epidermal cell lines with increasing 
tumorigenic potentials, ranging from nontumorigenic to highly malignant. We find 
that the BEC index gradually decreases whereas the Gal/Glu index increases with 
tumorigenicity, indicating that a progressive metabolic adaptation to aerobic 
glycolysis occurs in tumor cells associated with malignancy. Interestingly, this 
metabolic adaptation does not appear to be caused by damaged respiration, since 
the expression and activity of components of the respiratory chain complexes were 
unchanged in the cell lines. Moreover, the corresponding mitochondrial ATP 
synthetic abilities of the cell lines were found similar. The production of reactive 
oxygen species was also measured. A shift in ROS generation was found when 
compared nontumorigenic with tumorigenic cell lines, the latter exhibiting about 
threefold higher ROS levels than nontumorigenic cells. This result indicates that 
oxidative stress is an early event during tumor progression.  
  
3 
 
1. Introduction 
 
In 1927, Otto Warburg put forward the hypothesis that cancer cells undergo 
a shift in their metabolism from mitochondrial aerobic respiration to glycolysis 
followed by lactic acid fermentation that would occur even under normoxic 
conditions. Warburg also proposed that this altered metabolism is caused by 
defects in the oxidative phosphorylation (OXPHOS) pathway [1]. A bioenergetic 
signature of cancer cells was proposed by Cuezva and collaborators who showed 
that the expression of mitochondrial and glycolytic enzymatic markers varies 
significantly when comparing human carcinomas with paired normal tissues [2]. 
These authors analyzed a wide variety of tumors, including liver, kidney, colon, 
breast, lung, gastric and esophageal carcinomas, and concluded that OXPHOS 
function is reduced during neoplastic transformation. They defined a bioenergetic 
cellular index, the BEC index, which could be used to estimate the mitochondrial 
status in human tumors. However, the concept that the respiration of cancer cells 
is damaged is highly debated, in particular, since the discovery that proto-
oncogenes and tumor suppressor genes besides regulating signal transduction 
pathways involved in cell cycle control also affect cellular metabolism [3,4]. 
Nowadays, the idea that metabolic reprogramming is a hallmark of cancer is well 
established, regardless of whether the cause is or is not a defective respiration 
[3,5]. 
In this work, we have analyzed the OXPHOS status relative to glycolysis in a 
model of mouse skin carcinogenesis formed by four cell lines with increasing 
tumorigenic abilities. Mouse skin chemical carcinogenesis is a well-characterized 
model system to study the genetic and biochemical changes associated with tumor 
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initiation, promotion and progression. In this model, tumors are induced on the 
skin of mice by treatment with chemicals, either by the “two-stage” or “complete” 
carcinogenesis protocols [6]. The two-stage protocol involves treatment with a 
single dose of a carcinogen; i.e., 7, 12-dimethylbenz(a)anthracene (DMBA) 
followed by repeated applications of the tumor promoter 12-O-
tetradecanoylphorbol-13-acetate (TPA), which gives rise to the appearance of 
benign papillomas. A small fraction of papillomas spontaneously progress to 
malignant squamous cell carcinomas (SCCs), which lately can undergo an 
epithelial-mesenchymal conversion and form highly aggressive spindle cell 
carcinomas (SpCC) [7]. Complete carcinogenesis, on the other hand, involves 
repeated applications of the carcinogen DMBA. Here, DMBA-induced cell lines 
corresponding to different stages of skin carcinogenesis were used to evaluate 
whether OXPHOS dysfunctions that lead to increased glycolytic activity occur 
associated with tumor progression. 
 
2. Materials and Methods 
 
2.1. Cell lines, culture conditions and Gal/Glu index determination 
 
MCA3D cells were derived by treatment of a primary mouse epidermal 
keratinocyte culture with DMBA, followed by selection in high calcium medium 
that induces terminal differentiation of normal keratinocytes [8]. PB cells were 
obtained from a papilloma induced by two-stage carcinogenesis [9]. The A5 cell 
line was derived from the spindle component of a skin carcinoma induced by 
complete carcinogenesis [10], and CarC cells were explanted from a carcinoma 
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induced by two-stage carcinogenesis [11]. A summary of the origin and 
characteristics of the cell lines is presented in Supplementary Material (Table S1). 
MCA3D and PB cells have normal H-Ras genes, while both CarC and A5 cell lines 
exhibit an identical mutation at codon 61 of H-Ras [8,11,12]. Moreover, CarC cells 
show complete loss of the normal H-Ras allele [11] and have the Ink4 locus 
encoding the cell cycle regulators p15Ink4b, p16Ink4b and p19Arf deleted [13]. A5 
cells, on the other hand, have inactivated the tumor suppressor Trp53 gene 
encoding p53 [10], whereas CarC has normal Trp53 [14]. Cell lines were cultured 
in Dulbecco’s modified Eagle’s medium (DMEM)- Ham’s F12 medium (1:1) 
supplemented with 10% foetal bovine serum, 2mM L-glutamine, and antibiotics: 
100 g/ml ampicillin, 60 g/ml gentamicin and 2.5 g/ml amphotericin B. Cells 
were grown at 37ºC in a 5% CO2-humidified atmosphere. 
To compare the cell abilities to grow in the presence of either glucose or 
galactose as a sugar source, cells were transferred to sugar-free DMEM medium 
(Gibco) containing glucose (4.5 g/l) or galactose (0.9 g/l) plus the supplements 
cited above. Cells were incubated up to 8 days, refreshing the medium every 2 
days. Doubling times were calculated by applying the suitable formula DT = log 2 x 
(t – t0) / log N – log N0, where (t – t0) is the total days of incubation and N0 and N, 
the number of cells at the beginning and end of incubation, respectively. The 
Gal/Glu index is the ratio of the corresponding doubling times. 
 
 
 
 
2.2. Tumorigenicity assay 
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Cells were collected, washed with PBS (without calcium) and 
intradermally/subcutaneously injected at the two flanks of 8 week-old Balb/c 
female athymic nude mice (Harlan). Each animal received approximately 2x106 
cells/site. Tumor development was measured about twice per week and the size of 
tumors calculated from calliper measurements of two orthogonal diameters. 
 
2.3. Western-blot analysis and BEC index determination 
 
Collected cells were centrifuged and pellets frozen at -20º C until use. 
Pellets were lysed in cold RIPA buffer supplemented with complete protease 
inhibitors cocktail (Roche). The homogenates were kept in ice for at least 15 min 
and, if necessary, passed through a needle (0.4x13mm) to clarify the extracts 
before centrifuging at 13,000 rpm and 4ºC for 10 min. The supernatants were 
saved and the protein content determined with the BCA protein assay kit (Pierce). 
Extracts were stored frozen until use.  
Protein extracts (20 g) were separated in 10% SDS-PAGE gels and 
electrotransferred to either Immobilon-P or nitrocellulose membranes (Millipore). 
In order to determine the BEC index, membranes were probed with a polyclonal 
antibody against -ATPase [15] and, subsequently, with monoclonal antibodies 
recognizing Hsp60 and GAPDH (Stressgen). Appropriate secondary antibodies 
coupled to horseradish peroxidase were used, and peroxidase activity was 
developed using either an enhanced chemoluminiscence (ECL) kit (Amersham) or 
the Odissey detection system (nitrocellulose filters).  The signals obtained for each 
enzyme were quantified by densitometric analysis with Image J program. The BEC 
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index was calculated dividing the ratio -ATPase/Hsp60 by the value obtained for 
GAPDH [2]. 
 Determination of protein levels of the respiratory chain subunits was 
achieved as indicated above using 50 g protein extracts and monoclonal 
antibodies specific for COXI and NDUFA9 (Mitosciences). A monoclonal antibody  
against -actin (Sigma) was used as loading control. 
 
 
2.4. Determination of the activity and Blue Native electrophoresis of the respiratory 
chain complexes  
 
Enzymatic activity measurements were performed with homogenates 
obtained from 2x106 cells grown as described in section 2.1, washed in PBS and 
resuspended and sonicated in SETH buffer (250 mM sucrose, 2 mM EDTA, 100 U/L 
Heparine, 10 mM Tris-HCl, pH 7.4). The amount of protein was determined using 
the DC Protein Assay kit (Bio-Rad). The activities of the respiratory chain 
complexes I, II, III and IV and the mitochondrial mass marker citrate synthase were 
measured by spectrophotometric methods as previously described [16]. 
Blue native electrophoresis was performed as previously reported [17]. 
Mitochondrial protein extracts were obtained by treatment of the cells with 
2mg/ml digitonin followed by solubilization of the native complexes with 2% 
lauryl maltoside. Mitochondrial extracts (40 μg) were loaded on native 4-15% 
polyacrilamide gradient gels. After electrophoresis, proteins were transferred to a 
PVDF membrane (Millipore) and probed with the specific complex I monoclonal 
antibody NDUFA9 (Mitosciences).  
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In-gel activity assays were performed as described [17]. For complex I activity 
assay, gels were incubated 1-2 h at 37 ºC in 2 mM Tris–HCl, pH 7.4, 0.1 mg/ml 
NADH, and 2.5mg/ml nitrotetrazolium blue (NTB). Stained gels were washed with 
distilled water and scanned. 
 
2.5. ATP steady state levels  
 
ATP measurements were carried out as previously described [18], with 
some modifications. Briefly, 2x105 cells were grown for 24 hours in glu/gal 
medium in 35mm dishes to approximately 80% confluence and then incubated for 
2.5 hours in a solution (156 mM NaCl, 3 mM KCl, 2 mM MgSO4, 1,25 mM KH2PO4, 2 
mM CaCl2, 20 mM HEPES, pH 7,35) containing a combination of substrates and 
inhibitors: 5 mM 2-deoxy-D-glucose/ 1 mM pyruvate (for oxidative ATP) and 2-
deoxy-D-glucose/pyruvate/oligomycin (for residual ATP). After incubation, cells 
were washed with PBS and lysed with 1 mL of boiling 100 mM Tris, 4 mM EDTA, 
pH 7.75. Lysates were collected and incubated for two minutes at 100ºC, 
centrifuged 10 min at 13.000x g and 4ºC and supernatants frozen. ATP 
measurement was carried out with an Optocomp I luminometer (MGM 
instruments Inc), using the ATP bioluminescence assay kit CLS II (Roche Applied 
Science) according to manufacturer´s instructions. ATP levels were calculated with 
a standard ATP/luminescence curve and normalized by the total amount of protein 
measured with the Micro BCA Protein Assay Kit (Thermo Scientific). Assays were 
performed by duplicate in four independent experiments. 
 
2.6. Measurement of ROS generation 
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 The production of cytoplasmic and mitochondrial ROS was assessed using 
dichlorodihydrofluorescein diacetate (H2DCFDA, Molecular Probes) and 
MitoSOXTM  red (Invitrogen), respectively. 
For DCH2F-DA assays, cells (1x106) were grown for 48h in 
¨glucose/galactose medium¨ (DMEM plus 5% foetal bovine serum, 2 g/l glucose, 
2.5 g/l galactose, 100 U/ml penicillin and 100 g/ml streptomycin). Cells were 
collected, washed in PBS and counted. Approximately 5x105 cells were incubated 
in the absence or presence of 10 M 2´7-dichlorodihidrofluorescein diacetate 
(DCH2F-DA, Molecular Probes) in PBS, at 37ºC for 30min in the dark. After 
incubation, cells were washed, resuspended in 0.5 ml PBS, and immediately 
analysed with a FACScan flow cytometer (Beckton Dickinson). Mean fluorescence 
intensity was determined with CellQuest software (Beckton Dickinson). 
For measurement of mitochondrial ROS, 0.75x105 cells were grown in 
glu/gal medium. After addition of 5 M MitoSOXTM red and incubation at 37ºC for 
30 min in the dark, cells were collected in 0.5 ml glu/gal medium and immediately 
analysed with a FC500 MPL flow cytometer (Beckman Coulter). Forward and side 
scatter were used to gate the viable population of cells, and mean fluorescence 
intensity was determinate with MXP software (Beckman Coulter). Experiments 
were performed by triplicate in three independent experiments. 
 
 
 
3. Results and Discussion 
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3.1. Tumorigenic behavior of the cell lines 
 
We tested the tumorigenic capacities of the cell lines by transplantation in 
nude mice. The kinetics of tumor growth and the tumorigenic properties of the cell 
lines are shown in Fig 1. As can be seen, MCA3D cells were nontumorigenic. In 
contrast, PB cells induced tumors in about 67% of injection sites that required 
relatively long latency periods. A5 and CarC cell lines, on the other hand, were 
highly tumorigenic inducing tumors at all injection sites with short latency periods 
and similar kinetics of tumor growth, although CarC tumors appeared earlier (Fig. 
1A, B). Tumors induced by PB were histologically typed as moderately to well-
differentiated SCCs [9], whereas those induced by A5 and CarC were highly 
undifferentiated spindle cell carcinomas [10,11,14]. 
 
3.2. Mitochondrial function and tumorigenicity: BEC index and OXPHOS activity 
 
Cuezva and collaborators defined the BEC index (-F1-ATPase/GADPH 
protein ratio) as a bioenergetic mitochondrial index relative to the cellular 
glycolytic potential [2]. In patients with lung adenocarcinomas, a reduced BEC 
index correlated with worse prognosis [19]. In order to ascertain whether similar 
alterations of this bioenergetics signature occurred in our experimental model, we 
determined BEC index values for MCA3D, PB, A5 and CarC cell lines. As shown in 
Figure 2A, a clear decrease in the BEC index, ranging from 1.93 in nontumorigenic 
MCA3D to 0.53 in highly malignant CarC cells, was detected associated with 
enhanced tumorigenicity. To determine whether this reduction was due to an 
impaired OXPHOS function, the activity of the respiratory chain complexes was 
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measured in the different cell lines by spectrophotometric assays, as indicated in 
Materials and methods. No significant differences were found in the activities of 
the OXPHOS complexes (data not shown). The activity of the complexes was also 
measured using in-gel activity assays. The activity of complex I together with the 
levels of fully assembled complex observed in Blue Native gels are shown in Fig. 
2B. Also, the expression of proteins markers for complexes I and IV, as determined 
by Western blotting, is shown in Fig. 2C. No significant differences in these 
parameters were found between the different cell lines, in accordance with the 
spectrophotometric analysis.  
The gradual decline in the BEC signature associated with enhanced 
tumorigenicity observed in our cell lines is in line with the proposal of reduced 
BEC index as a bad prognostic factor in assessing clinical outcome for cancer 
patients [2,19]. Apparently, this decrease is not caused by significant changes in 
the protein composition or activity of the mitochondrial respiratory chain 
complexes.   
 
3.3. Glycolisis and tumorigenicity:  Gal/Glu index  
 
Since the activity of the respiratory chain complexes appeared not to be 
affected in tumorigenic cell lines, the observed reduction in the BEC index could be 
explained by an increased glycolytic activity or by a defective mitochondrial 
function not observed in the measurements of the activity of the OXPHOS 
complexes. To test these possibilities, we measured the relative ability of the 
different cell lines to grow in galactose versus high glucose medium (Gal/Glu 
index). Galactose is not utilized efficiently as a glycolytic substrate; therefore only 
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cells with a fully functional OXPHOS system grow in these conditions [20]. Cells 
with efficient OXPHOS grow equally well in media supplemented with either 
galactose or glucose. 
The doubling times of MCA3D, PB, A5 and CarC cells growing in the 
presence of either galactose or glucose were measured and the Gal/Glu indexes 
calculated. We observed an increase in the Gal/Glu index, ranging from 1.12 in 
MCA3D to 1.67 in CarC, which correlated with the tumorigenic potential of the cell 
lines (Fig. 3). Interestingly, cells grew poorly in the presence of galactose, and the 
observed increase in Gal/Glu index was mainly due to the most efficient growth of 
tumorigenic cell lines in high glucose medium.  
To further investigate the OXPHOS capacity of the cells, we evaluated the 
ATP contents when the cells grew in 2-deoxyglucose, condition in which ATP is 
exclusively produced through OXPHOS (Figure 3B). Interestingly the ATP levels 
were similar in all cases, thus indicating that the four cell lines can produce 
equivalent amounts of ATP via OXPHOS. The mitochondrial origin of ATP is clearly 
demonstrated with the incubation in the presence of oligomycin, an inhibitor of 
ATP synthase, which abolished the synthesis completely. 
Taken together, the variations in BEC and Gal/Glu indexes observed in our 
cell model likely reflect a progressive metabolic adaptation from OXPHOS to 
glucose fermentation associated with increased malignancy in neoplastic cells. 
This metabolic change appears not to be caused by impairment of mitochondrial 
respiration as the capacity to synthesize ATP via OXPHOS and to grow in galactose 
medium are comparable in all cell lines studied. 
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3.4. ROS generation and tumorigenicity 
 
Mitochondria are considered the main source of reactive oxygen species 
(ROS), and ROS production is generally associated with impairments of the 
respiratory chain [21]. Therefore, in order to ascertain whether alterations in the 
generation of ROS also occur associated with tumorigenicity, we measured the 
intracellular ROS levels in the different cell lines. A shift in the generation of ROS 
was found when comparing nontumorigenic MCA3D cells with tumorigenic PB, A5 
and CarC cell lines (Fig. 4). Tumorigenic cell lines produced similar amounts of ROS 
that were higher (about threefold) than the amount of ROS generated by MCA3D. 
Since papilloma-derived PB is only moderately tumorigenic and spindle carcinoma 
cell lines A5 and CarC represent advanced stages of skin carcinogenesis [7], this 
finding suggests that oxidative stress increases early during tumor progression.  
 To learn of the intracellular source of ROS, we determined the levels of 
mitochondrial superoxide anion using MitoSOX, a specific mitochondrial ROS 
reagent. Interestingly, the results found (Fig S1) were similar in the different cell 
lines except in the case of PB that showed a very low level of superoxide, indicating 
that ROS production in this particular cell line mostly occurs at a site different from 
the mitochondria, likely the endoplasmic reticulum and/or the plasma membrane. 
Likewise, since the levels of mitochondrial superoxide anion of A5 and CarC are 
similar to that of MCA3D, the increase observed in the total ROS levels produced by 
the former cell lines with respect to the latter (Fig. 4) seems to be generated 
outside the mitochondria. 
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In summary, the relationship between oxidative function, glycolysis and 
tumorigenicity was analyzed in four epidermal cell lines representing an in vitro 
model of tumor progression, in which two indexes, BEC and Gal/Glu, were 
determined. In both cases, a gradual increase in glycolytic activity compared to 
OXPHOS function was observed associated with tumorigenicity. Notwithstanding, 
alterations in the expression or activity of components of the respiratory chain 
complexes were not found. In agreement, the corresponding mitochondrial ATP 
synthetic abilities of the cell lines were similar. These results agree well with 
recent ideas suggesting that mitochondria are not necessarily damaged in cancer 
cells, but cellular metabolism is reprogrammed from mitochondrial respiration to 
aerobic glycolysis in order to support anabolic growth. Thus, the ATP required for 
growth is mainly obtained through inefficient glycolysis that otherwise generates 
increased levels of biosynthetic precursors necessary to sustain a high rate of cell 
proliferation [3,4,5]. The mechanisms involved in the metabolic adaptation of 
cancer cells are still poorly understood but they seem to be directed by alterations 
in proto-oncogenes and tumor suppressor genes. The cell model presented in this 
work represents a suitable tool to investigate the molecular mechanisms leading to 
the metabolic reprogramming of cancer cells. 
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Legends to Figures 
 
 
18 
 
Fig. 1. Tumorigenic characteristics of the cell lines. Cells were injected into the two 
flanks of nude mice and the size of tumors was measured every 2-3 days as 
indicated in Materials and methods. (A) Kinetics of tumor growth. The average 
values (+ SD) of tumor size are indicated (PB, n = 4; A5, n = 10; CarC, n = 6). (B) 
Incidence of tumors induced by the cell lines. The table records the number of 
tumors developed (higher than 0.5 cm2) per total number of injection sites. MCA3D 
cells gave rise to small cysts below 0.5 cm2 that regressed or remained stable at the 
end of the experiment (40 days postinjection). The latency period was estimated as 
the time needed for tumors to reach a size of 0.5 cm2. SCC, squamous cell 
carcinoma; SpCC, spindle cell carcinoma.  
 
Fig 2. BEC index decreases with tumorigenicity. (A) The expression of -ATPase, 
Hsp60 and GAPDH was determined by Western blotting. BEC indexes in the table 
below were calculated as shown in Materials and methods and are expressed as 
the average (+ SD) values obtained from five independent experiments. Statistical 
analysis was performed by the Student´s t-test. Significant differences with respect 
to MCA3D were observed. ***P<0.001. 
 (B) In-gel activity assay and blue-native electrophoresis of complex I was 
performed as described in Materials and Methods. (C) Analysis of Cox I (complex 
V) and NDUFA9 (complex I) expression by Western blotting. -actin was used as a 
loading control. 
 
Fig 3. (A) Gal/Glu index increases with tumorigenicity. Graphs represent the 
number of cells versus the incubation period in medium containing either glucose 
or galactose; a representative experiment is shown. Gal/Glu indexes in the table at 
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the bottom were calculated as the average (+ SD) of duplicate determinations of 3-
5 independent experiments. Statistical analysis was performed by the Student´s t-
test. Significant differences with respect to MCA3D were observed in A5 and CarC. 
*P<0.02. (B) Cell lines synthesize similar oligomycin-sensitive ATP steady state 
levels. The ATP synthesized by the cell lines was determined in the presence of 2-
deoxyglucose as described in Materials and methods. The mitochondrial origin of 
the measured ATP was authenticated by the complete inhibition of its production 
with oligomycin. 
 
Fig 4. Increased ROS generation is an early event in tumorigenesis. The mean 
fluorescence intensity of a representative experiment is shown in the absence 
(gray) and presence (blue) of reagent. The diagram at the bottom represents the 
mean values (+ SD) of ROS levels plotted from triplicate determinations of four 
independent experiments. Statistical analysis was performed by the Student´s t-
test. **P<0.01, *P<0.05. 
 
Fig S1. Mitochondrial ROS production in the different cell lines. Cells were 
incubated in the presence of MitoSOX and the resulting fluorescence intensity 
measured as described in Materials and methods. The diagram represents the 
mean values (+ SD) of ROS levels plotted from triplicate determinations of three 
independent experiments. Statistical analysis was performed by the Student´s t-
test. Significant differences were observed in PB versus MCA3D. No significant 
differences were observed in the levels of MCA3D with respect to the other two 
cell lines. ***P<0.001.  
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Table S1. Summary of cell lines characteristics 
_____________________________________________________________________________________________________________________________________________________ 
Cell line  Origin         Phenotype  H-Ras   Trp53                Ink4   
          mutation  inactivation               deletion 
_____________________________________________________________________________________________________________________________________________________ 
MCA3D DMBA-treated primary keratinocytes     E    No       No                 No   
PB  DMBA/TPA-induced papilloma      E    No       ND                 ND   
A5  DMBA-induced carcinoma       F           Codon 61      Yes                 No   
CarC  DMBA/TPA-induced carcinoma      F           Codon 61       No                 Yes   
              Loss of normal allele 
______________________________________________________________________________________________________________________________________________________ 
DMBA, 7, 12-dimethylbenz(a)anthracene; TPA, 12-O-tetradecanoylphorbol-13-acetate;  E, epithelial; F, fibroblastic; ND, not determined 
 
 

